Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 10 | 2024 | 1068 | 1.030 |
Why?
|
| Vitis | 7 | 2019 | 37 | 0.990 |
Why?
|
| Plant Extracts | 7 | 2019 | 303 | 0.810 |
Why?
|
| Isothiocyanates | 2 | 2012 | 20 | 0.600 |
Why?
|
| Trypsin Inhibitor, Kazal Pancreatic | 1 | 2018 | 4 | 0.580 |
Why?
|
| Annexin A2 | 1 | 2018 | 6 | 0.580 |
Why?
|
| Chaperonin 60 | 1 | 2018 | 17 | 0.570 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 112 | 0.530 |
Why?
|
| Cell-Matrix Junctions | 1 | 2012 | 2 | 0.370 |
Why?
|
| RNA, Transfer, Amino Acid-Specific | 1 | 2012 | 13 | 0.370 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2012 | 28 | 0.370 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2012 | 29 | 0.370 |
Why?
|
| Stilbenes | 2 | 2008 | 44 | 0.330 |
Why?
|
| Selenoproteins | 1 | 2012 | 146 | 0.330 |
Why?
|
| Anticarcinogenic Agents | 3 | 2015 | 74 | 0.270 |
Why?
|
| Transcription Factors | 3 | 2019 | 722 | 0.260 |
Why?
|
| Chemoprevention | 2 | 2015 | 41 | 0.260 |
Why?
|
| Dietary Fiber | 1 | 2006 | 50 | 0.250 |
Why?
|
| Diet Records | 1 | 2006 | 58 | 0.250 |
Why?
|
| Nutrition Assessment | 1 | 2006 | 79 | 0.240 |
Why?
|
| Animals, Genetically Modified | 1 | 2005 | 100 | 0.220 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 2024 | 5 | 0.220 |
Why?
|
| Carcinogens | 1 | 2005 | 126 | 0.220 |
Why?
|
| Antigens, Surface | 1 | 2024 | 50 | 0.220 |
Why?
|
| Glutathione | 1 | 2005 | 170 | 0.210 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 928 | 0.200 |
Why?
|
| Disease Progression | 2 | 2018 | 661 | 0.190 |
Why?
|
| Cell Proliferation | 2 | 2008 | 1420 | 0.190 |
Why?
|
| Caspase 3 | 2 | 2018 | 226 | 0.160 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 366 | 0.160 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2015 | 134 | 0.160 |
Why?
|
| Mice, Nude | 3 | 2024 | 403 | 0.160 |
Why?
|
| Mice | 6 | 2024 | 6490 | 0.160 |
Why?
|
| Cathepsin L | 2 | 2019 | 16 | 0.150 |
Why?
|
| CCAAT-Binding Factor | 1 | 2019 | 3 | 0.150 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 1554 | 0.150 |
Why?
|
| Male | 11 | 2024 | 22779 | 0.150 |
Why?
|
| Nanoparticles | 1 | 2024 | 449 | 0.150 |
Why?
|
| Indans | 1 | 2018 | 14 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 3 | 2024 | 686 | 0.140 |
Why?
|
| Estrogen Receptor alpha | 1 | 2019 | 120 | 0.140 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 144 | 0.140 |
Why?
|
| Piperidines | 1 | 2018 | 80 | 0.140 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1266 | 0.140 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2024 | 339 | 0.130 |
Why?
|
| Humans | 14 | 2024 | 42163 | 0.130 |
Why?
|
| Cell Line, Tumor | 6 | 2024 | 2598 | 0.130 |
Why?
|
| Repressor Proteins | 1 | 2019 | 267 | 0.130 |
Why?
|
| Animals | 7 | 2024 | 16695 | 0.120 |
Why?
|
| Ethanol | 1 | 2018 | 221 | 0.120 |
Why?
|
| Autophagy | 1 | 2016 | 136 | 0.120 |
Why?
|
| Neuroprotective Agents | 1 | 2018 | 267 | 0.120 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 48 | 0.110 |
Why?
|
| Apoptosis | 5 | 2019 | 1541 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 150 | 0.110 |
Why?
|
| Superoxides | 1 | 2014 | 57 | 0.110 |
Why?
|
| Neoplasms | 1 | 2005 | 1341 | 0.110 |
Why?
|
| Genotype | 2 | 2017 | 796 | 0.100 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2012 | 5 | 0.090 |
Why?
|
| Cell Growth Processes | 1 | 2012 | 43 | 0.090 |
Why?
|
| Selenocysteine | 1 | 2012 | 54 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 62 | 0.090 |
Why?
|
| Cell Survival | 2 | 2019 | 934 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2012 | 1010 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 933 | 0.070 |
Why?
|
| Oncogene Proteins | 1 | 2007 | 22 | 0.070 |
Why?
|
| Oncogene Protein v-akt | 1 | 2007 | 20 | 0.070 |
Why?
|
| Androgens | 1 | 2008 | 107 | 0.070 |
Why?
|
| Seeds | 1 | 2007 | 46 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 1804 | 0.060 |
Why?
|
| Nutritional Sciences | 1 | 2006 | 25 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 1 | 2007 | 506 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2024 | 979 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 201 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2007 | 184 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2006 | 224 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 2803 | 0.060 |
Why?
|
| Colonic Polyps | 1 | 2006 | 70 | 0.060 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2005 | 12 | 0.060 |
Why?
|
| Glutathione Reductase | 1 | 2005 | 19 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 602 | 0.060 |
Why?
|
| Educational Status | 1 | 2006 | 335 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 90 | 0.060 |
Why?
|
| Glutathione Peroxidase | 1 | 2005 | 100 | 0.060 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2005 | 69 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2005 | 169 | 0.050 |
Why?
|
| Aged | 3 | 2017 | 7982 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 1679 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 1112 | 0.050 |
Why?
|
| Cell Movement | 2 | 2019 | 640 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2015 | 2111 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 1058 | 0.050 |
Why?
|
| Zebrafish | 1 | 2024 | 146 | 0.050 |
Why?
|
| Feeding Behavior | 1 | 2006 | 461 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2005 | 223 | 0.050 |
Why?
|
| Female | 3 | 2015 | 24018 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 518 | 0.040 |
Why?
|
| Middle Aged | 3 | 2017 | 11819 | 0.040 |
Why?
|
| Cell Line | 1 | 2005 | 1416 | 0.040 |
Why?
|
| Central Nervous System Depressants | 1 | 2018 | 42 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2018 | 189 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2018 | 134 | 0.030 |
Why?
|
| Recurrence | 1 | 2017 | 149 | 0.030 |
Why?
|
| Rats | 1 | 2005 | 3701 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2017 | 141 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2017 | 158 | 0.030 |
Why?
|
| Caspase 12 | 1 | 2016 | 5 | 0.030 |
Why?
|
| Chloroquine | 1 | 2016 | 19 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 436 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2016 | 76 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 534 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2016 | 59 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 599 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 254 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 152 | 0.030 |
Why?
|
| Osteoprotegerin | 1 | 2015 | 17 | 0.030 |
Why?
|
| Osteoclasts | 1 | 2015 | 28 | 0.030 |
Why?
|
| RANK Ligand | 1 | 2015 | 19 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2015 | 57 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 1 | 2015 | 51 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 452 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 230 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2015 | 97 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 284 | 0.030 |
Why?
|
| Proteomics | 1 | 2016 | 363 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2016 | 534 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 1051 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 1729 | 0.020 |
Why?
|
| Adult | 1 | 2006 | 13458 | 0.020 |
Why?
|
| Metribolone | 1 | 2008 | 3 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2008 | 28 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 98 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 129 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 310 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 649 | 0.020 |
Why?
|
| Estradiol | 1 | 2008 | 269 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 683 | 0.010 |
Why?
|